Published in Ann Intern Med on November 01, 1984
Colorectal neoplasia in acromegaly. Gut (1999) 1.42
Screening guidelines for colorectal cancer and polyps in patients with acromegaly. Gut (2002) 1.07
Growth hormone treatment in infertility: a short review. Indian J Pediatr (1992) 0.75
Protein synthesis in relation to ripening of pome fruits. Plant Physiol (1968) 4.28
Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer (1998) 3.55
Improving care for minority children with asthma: professional education in public health clinics. Pediatrics (1997) 2.02
Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med (1995) 1.95
Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? J Virol (2002) 1.91
Functional, angiographic and intracoronary Doppler flow characteristics in symptomatic patients with myocardial bridging: effect of short-term intravenous beta-blocker medication. J Am Coll Cardiol (1996) 1.79
Colonic polyps in patients with acromegaly. Ann Intern Med (1982) 1.71
Thyroid hormone and hemodynamic regulation of beta-myosin heavy chain promoter in the heart. Endocrinology (1996) 1.66
Cowpea mosaic virus RNAs have neither m7GpppN ... nor mono-, di- or triphosphates at their 5' ends. Cell (1977) 1.62
Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design. J Virol (2001) 1.57
Silent thyrotoxic thyroiditis in association with chronic adrenocortical insufficiency. Arch Intern Med (1980) 1.45
Post-infectious encephalitis in adults: diagnosis and management. J Infect (2009) 1.41
[Cardiac diffusion MRI of recent and chronic myocardial infarction: preliminary results]. J Radiol (2009) 1.40
Effects of adrenergic agonists on the growth and gene expression of the transplanted heart. J Lab Clin Med (1994) 1.39
[Abdominal organ retrieval: strategies to improve quality]. Chirurg (2013) 1.38
Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med (1990) 1.37
Acute effects of thyroid hormone on vascular smooth muscle. Thyroid (1996) 1.35
Thyroid carcinoma presenting as an enlarged cervical lymph node. Am J Surg (1993) 1.33
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid (1998) 1.33
Pre-illness dietary factors in inflammatory bowel disease. Gut (1997) 1.29
Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin. Cancer Treat Rep (1984) 1.25
Thyroid hormone and the cardiovascular system. Minerva Endocrinol (2004) 1.18
Minimal post-transcriptional modification of yeast mitochondrial ribosomal RNA. J Mol Biol (1975) 1.14
Hypothyroidism presenting as muscle stiffness and pseudohypertrophy: Hoffmann's syndrome. Am J Med (1981) 1.12
Effect of liposomes containing cholesterol on adenylate cyclase activity of cultured mammalian fibroblasts. Biochim Biophys Acta (1978) 1.11
Functional characteristics of myocardial bridging. A combined angiographic and intracoronary Doppler flow study. Eur Heart J (1997) 1.09
Comparative pharmacokinetics of cisplatin and three analogues in mice and humans. Cancer Res (1987) 1.08
Dynamic gadolinium-enhanced subtraction MR imaging--a simple technique for the early diagnosis of Legg-Calvé-Perthes disease: preliminary results. Pediatr Radiol (1997) 1.08
Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of cisplatin. Clin Pharmacol Ther (1986) 1.07
Urban development and death: Bombay City, 1870-1914. Mod Asian Stud (1986) 1.07
Fat emboli in bilateral total knee arthroplasty. Predictive factors for neurologic manifestations. Clin Orthop Relat Res (1989) 1.06
Unusual manifestations of hypothyroidism. Arch Intern Med (1984) 1.06
New insights into salivary lactate dehydrogenase of human subjects. J Lab Clin Med (2001) 1.05
Thyroid hormone effects on cardiac gene expression independent of cardiac growth and protein synthesis. Am J Physiol (1992) 1.05
The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries. Anesth Analg (1997) 1.03
Activation of myocardial adenyl cyclase by histamine in guinea pig, cat, and human heart. J Clin Invest (1971) 1.03
Pharmacokinetics of carboplatin after intraperitoneal administration. Cancer Chemother Pharmacol (1988) 1.02
A high molecular weight phosphoprotein in cultured fibroblasts that associates with polymerized tubulin. Exp Cell Res (1978) 1.02
Characterization of the human multidrug resistance protein containing mutations in the ATP-binding cassette signature region. Biochem J (1997) 0.99
Thyroid disease in progressive systemic sclerosis: increased frequency of glandular fibrosis and hypothyroidism. Ann Intern Med (1981) 0.98
Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat. Am J Physiol Endocrinol Metab (2000) 0.97
A prospective randomized clinical study of thyroid hormone treatment after operations for complex congenital heart disease. J Thorac Cardiovasc Surg (2001) 0.97
Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implications. Eur J Cancer Clin Oncol (1982) 0.97
Contraction regulates myosin synthesis and myosin content of cultured heart cells. Am J Physiol (1985) 0.97
Massive breast enlargement in a patient receiving D-penicillamine for systemic sclerosis. J Rheumatol (1985) 0.96
New perspectives on thyroid hormone, catecholamines, and the heart. Am J Med (1984) 0.95
Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy. Diabet Med (2007) 0.95
Skin tags: a cutaneous marker for colonic polyps. Ann Intern Med (1983) 0.95
Lack of association between smoking and inflammatory bowel disease in Jewish patients in Israel. Gastroenterology (1995) 0.94
Infective endocarditis with symptomatic cerebral complications: contribution of cerebral magnetic resonance imaging. Cerebrovasc Dis (2013) 0.93
Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart. J Clin Invest (1986) 0.93
Cardiac protein degradation in acute overload in vitro: reutilization of amino acids. Am J Physiol (1973) 0.93
Thyroid hormone increases pacemaker activity in rat neonatal atrial myocytes. J Mol Cell Cardiol (2001) 0.92
Importance of Holter monitoring in patients with periodic cerebral symptoms. Ann Neurol (1977) 0.92
Effect of cigarette smoke on salivary proteins and enzyme activities. Arch Biochem Biophys (2000) 0.92
Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma. Ann Intern Med (1998) 0.91
Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. J Clin Endocrinol Metab (1991) 0.91
Minimal methylation of yeast messenger RNA. Mol Biol Rep (1976) 0.91
Hyperthyroid myopathy and the response to treatment. Thyroid (1991) 0.90
Posttranscriptional modification of myosin heavy-chain gene expression in the hypertrophied rat myocardium. Proc Natl Acad Sci U S A (1994) 0.90
Effects of thyroid hormone on action potential and repolarizing currents in rat ventricular myocytes. Am J Physiol Endocrinol Metab (2000) 0.90
Diabetic management in patients with renal failure. Diabetes Care (1982) 0.90
Thyroid hormone regulation of phospholamban phosphorylation in the rat heart. Endocrinology (2000) 0.90
Protein binding of five platinum compounds. Comparison of two ultrafiltration systems. Cancer Chemother Pharmacol (1986) 0.89
Colchicine stimulates the rate of contraction of heart cells in culture. Cardiovasc Res (1983) 0.88
Differential regulation of SR calcium transporters by thyroid hormone in rat atria and ventricles. Am J Physiol Heart Circ Physiol (2001) 0.87
Measurement of myosin adenosinetriphosphatase and myosin content in cultured heart cells. Arch Biochem Biophys (1985) 0.87
Quantitative determination of cisplatin in body fluids by liquid chromatography with quenched phosphorescence detection. J Pharm Biomed Anal (1987) 0.87
Thyroid hormone regulation of alpha-myosin heavy chain promoter activity assessed by in vivo DNA transfer in rat heart. Biochem Biophys Res Commun (1991) 0.86
Occurrence of polyamines in coliphages T5, phiX174 and in phage-infected bacteria. J Gen Virol (1975) 0.86
Characterization of 125I-glucagon binding in a solubilized preparation of cat myocardial adenylate cyclase. Further evidence for a dissociable receptor site. J Biol Chem (1974) 0.86
Idiopathic granulomatous hypophysitis. Neurosurg Focus (1996) 0.86
Solubilized myocardial adenylate cyclase. Restoration of histamine responsiveness by phosphatidylserine. J Clin Invest (1972) 0.86
Pharmacokinetics of carboplatin after i.v. administration. Cancer Treat Rep (1987) 0.86
Thyroid hormone and the cardiovascular system: from theory to practice. J Clin Endocrinol Metab (1994) 0.86
Chemical reactivity of cisplatin bound to human plasma proteins. Cancer Chemother Pharmacol (1987) 0.85
Characterization of a calcium-activated protease that hydrolyzes a microtubule-associated protein. Arch Biochem Biophys (1981) 0.85
Resolution of abnormal muscle enzyme studies in hypothyroidism. Am J Med Sci (1980) 0.85
Regulation of rat cardiac Kv1.5 gene expression by thyroid hormone is rapid and chamber specific. Endocrinology (1999) 0.85
Thyroid hormone stimulates Na, K-ATPase gene expression in the hemodynamically unloaded heterotopically transplanted rat heart. Thyroid (2000) 0.85
Presentation of an unusual benign liver tumor: primary hepatic glomangioma. Scand J Gastroenterol (2002) 0.85
Prospective evaluation of thyroid function in patients with systemic sclerosis (scleroderma). J Rheumatol (1986) 0.85
Identification of a contractile-responsive element in the cardiac alpha-myosin heavy chain gene. J Biol Chem (1995) 0.84
The chemical reactivity of the modulating agent WR2721 (ethiofos) and its main metabolites with the antitumor agents cisplatin and carboplatin. Biochem Pharmacol (1991) 0.84
Preserved contractile function despite atrophic remodeling in unloaded rat hearts. Am J Physiol Heart Circ Physiol (2001) 0.84
Psychiatric and neuropsychological response to propranolol in Graves' disease. Biol Psychiatry (1988) 0.84
Effects of lithium on the endocrine system: a review. J Lab Clin Med (1987) 0.84
Brain MRI findings in neurologically asymptomatic patients with infective endocarditis. AJNR Am J Neuroradiol (2013) 0.84
Thyroid hormone: targeting the vascular smooth muscle cell. Circ Res (2001) 0.83
Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms. Am J Med (1989) 0.83
Myosin heavy chain gene expression in neonatal rat heart cells: effects of [Ca2+]i and contractile activity. Am J Physiol (1997) 0.83
Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemia. J Thorac Cardiovasc Surg (1995) 0.83
Evidence for a dissociable glucagon binding site in a solubilized preparation of myocardial adenylate cyclase. J Biol Chem (1973) 0.82
A psychiatric and neuropsychological study of patients with untreated Graves' disease. Gen Hosp Psychiatry (1988) 0.82
In vivo regulation of recombinant cardiac myosin heavy chain gene expression by thyroid hormone. Endocrinology (1993) 0.82
Thyroid hormone-targeting the heart. Endocrinology (2001) 0.82
Evidence for cellular mediated immunity in an animal model of autoimmune pituitary disease. Endocr Res Commun (1982) 0.81
Diffusion weighted imaging of cerebellar lesions in Wernicke's encephalopathy. J Neuroradiol (2006) 0.81